Pregabalin - Med Map - Medication ATI worksheet for Pregablin PDF

Preview

Summary

Medication ATI worksheet for Pregablin...

Description

ACTIVE LEARNING TEMPLATE:

Medication

Joseline landa MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ pregabalin - Lyrica, Lyrica CR CATEGORY CLASS Gamm ______________________________________________________________________ a-aminobutyric acid (GABA) analogue and Analgesic, anticonvulsant ST UDENT NAME _____________________________________

PURPOSE OF MEDICATION

Expected Pharmacological Action Binds to alpha2-delta site, an auxiliary subunit of voltage calcium channels, in CNS tissue where it may reduce calcium-dependent release of several neurotransmitters, possibly by modulating calcium channel function. With fewer neurotransmitters, pain sensation and seizure activity decline.

Therapeutic Use

Therapeutic use consists of painkilling to relieve pain; used to prevent or reduce the severity of epileptic fits

Complications CV: Chest pain, heart failure, peripheral edema, ventricular fibrillation EENT: Amblyopia, blurred vision, conjunctivitis, decreased visual acuity, diplopia, dry mouth, nystagmus, otitis media, sinusitis, tinnitus, visual field defect ENDO: Gynecomastia, hypoglycemia GI: Abdominal distention or pain, constipation, diarrhea, flatulence, gastroenteritis, GI hemorrhage, increased appetite, nausea, vomiting GU: Acute renal failure, anorgasmia, decreased libido, glomerulitis, impotence, nephritis, urinary frequency, urinary incontinence, urine retention

Medication Administration

CAPSULES, ORAL SOLUTION: 50 mg three times a da E.R. TABLETS: 165 mg once daily after evening meal,

Contraindications/Precautions

Hypersensitivity to pregabalin or its components

Interactions

lorazepam, oxycodone: Additive effects on cognitive and gross motor function

Nursing Interventions -Monitor patient closely for adverse reactions. Notify prescriber if significant adverse reactions persist. Be aware that children younger than 4 years has a higher change of experiencing pneumonia, somnolence, or viral infection. -Monitor patient closely for evidence of suicidal behavior or thinking, especially when therapy starts or dosage changes Client Education

Evaluation of Medication Effectiveness

Upon close analysis of the medication, I believe the medication is very effective due to its low adverse reactions and contraindications. The medication is easy to take without lethal

ACTIVE LEARNING TEMPLATES

-Instruct patient prescribed extendedrelease tablets not to chew, crush, or split tablets but to swallow tablets whole. Tell patient to take tablets after evening meal. - Urge patient to avoid hazardous activities until she knows how drug affects he r. - Warn against stopping pregabalin abruptly. Tell patient that when pregabalin is no longer needed, the dosage should be tapered gradually over a minimum of one week before it is discontinued.

THERAPEU TIC P ROCEDURE

A7...